[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BiopharmIQ by Amp [@BiopharmIQ](/creator/twitter/BiopharmIQ) on x 25.7K followers Created: 2023-06-17 19:07:09 UTC Biotech Weekly News: Biggest Moves 6/12-6/16👀📈📉 🟢 $KDNY XX% To acquire by #NVS & Ph1/2 data at ERA $AGRX XX% Increase Rx thru telemedicine $GRCL XX% Longer term follow-up data @ EHA 2023 $DERM XX% Topline data from Ph1 trial of DFD-29 $PRAX XX% Public Offering $0.95/share $VERV XX% Collab w/ $LLY on gene editing $ABOS XX% Topline results of ACU193 AAIC '23 $XFOR X% To join Russell 3000 index 🔴 $OMER -XX% Late breaking EHA presentation $CHRS -XX% To acquire $SURF $CRVS -XX% New data for CPI-818 $MRSN -XX% Partial clinical hold Check out the image for more details!📸  XXXXX engagements  **Related Topics** [$xfor](/topic/$xfor) [$abos](/topic/$abos) [$lly](/topic/$lly) [collab](/topic/collab) [$verv](/topic/$verv) [$095share](/topic/$095share) [primary market](/topic/primary-market) [$prax](/topic/$prax) [Post Link](https://x.com/BiopharmIQ/status/1670146078891491330)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BiopharmIQ by Amp @BiopharmIQ on x 25.7K followers
Created: 2023-06-17 19:07:09 UTC
Biotech Weekly News: Biggest Moves 6/12-6/16👀📈📉
🟢 $KDNY XX% To acquire by #NVS & Ph1/2 data at ERA $AGRX XX% Increase Rx thru telemedicine $GRCL XX% Longer term follow-up data @ EHA 2023 $DERM XX% Topline data from Ph1 trial of DFD-29 $PRAX XX% Public Offering $0.95/share $VERV XX% Collab w/ $LLY on gene editing $ABOS XX% Topline results of ACU193 AAIC '23 $XFOR X% To join Russell 3000 index
🔴 $OMER -XX% Late breaking EHA presentation $CHRS -XX% To acquire $SURF $CRVS -XX% New data for CPI-818 $MRSN -XX% Partial clinical hold
Check out the image for more details!📸
XXXXX engagements
Related Topics $xfor $abos $lly collab $verv $095share primary market $prax
/post/tweet::1670146078891491330